Ligand Pharmaceuticals Inc (LGND)
SBC to Revenue
21.44%
Quarterly · Period ending:
LGND SBC to Revenue
Latest reported21.44%period ending
Latest reported21.44%period ending
LGND Quarterly SBC/Revenue (0.00% → 21.44%)
Latest values, visible window
High-resolution chart · PNG
LGND sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 21.4356% | |
| 20.4864% | |
| 23.9165% | |
| 12.7714% | |
| 0% | |
| 0% | |
| 17.5745% | |
| 50.6273% | |
| 26.6307% | |
| 23.6749% | |
| 0% | |
| 20.9444% | |
| 27.3344% | |
| 0% | |
| 0% | |
| 21.2712% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 15.2403% | |
| 14.252% | |
| 18.4955% | |
| 17.7668% | |
| 17.0471% | |
| 23.3307% | |
| 25.3829% | |
| 26.2977% | |
| 12.2965% | |
| 10.0839% | |
| 11.9791% | |
| 5.3441% | |
| 8.1112% | |
| 17.8305% | |
| 15.7243% | |
| 16.5172% | |
| 20.6547% | |
| 13.6258% | |
| 22.7763% | |
| 23.8103% | |
| 13.8896% | |
| 13.9062% | |
| 16.0217% | |
| 20.4202% | |
| 19.9562% | |
| 10.7618% | |
| 24.7245% | |
| 28.5256% | |
| 12.9528% | |
| 10.2938% | |
| 11.7878% | |
| 15.5741% | |
| 9.6472% | |
| 6.9747% | |
| 15.8902% | |
| 24.2773% | |
| 12.5798% | |
| 5.4499% | |
| 16.5476% | |
| 16.6689% | |
| 11.6016% | |
| 7.8934% | |
| 7.1392% | |
| 14.2686% | |
| 10.4733% | |
| 6.6109% | |
| 9.3786% | |
| 11.5881% | |
| 8.6589% | |
| 29.1145% | |
| 0% | |
| 0% | |
| 20.435% | |
| 131.3692% | |
| 0% | |
| 0% | |
| 2,363.4043% | |
| 15.6402% | |
| 0% | |
| 0% | |
| 1.5975% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |